Dr. Mark DeBoer, MD
Claim this profileUniversity of Virginia
Studies Type 1 Diabetes
Studies Asthma
4 reported clinical trials
4 drugs studied
Affiliated Hospitals
Clinical Trials Mark DeBoer, MD is currently running
Artificial Pancreas
for Type 1 Diabetes
This study designed to assess changes in control of Type 1 Diabetes in pubertal adolescents over a two year period. There are two arms/substudies, the first being a longitudinal randomized controlled trial and the second an observational study.
Recruiting1 award N/A16 criteria
Fully Closed Loop System
for Type 1 Diabetes
Protocol Overview/Synopsis This study will be conducted at 3 sites, with each site performing a session with up to 6 participants with a lower HbA1c (\<8.0%) in one of 3 age categories (26-60, 18-25, or 14-17 years) followed by a session of up to 6 additional participants with a higher HbA1c (8.0-12.0%) with the same age categories (26-60, 18-25, or 14-17 years). The trial will aim to complete a total of 36 participants: 12 total participants within each age category and 18 participants within each HbA1c category; 12 participants at each site. The study may enroll up to 70 participants to account for dropouts across the study. The study will be performed for 5 days and 4 nights at a local hotel/rental. Following the hotel session, participants will undergo a 7 day/6-night remote monitored at-home use session. The study will also conduct a two-week control period gathering data on glycemic control and insulin administration with the participants usual care therapy. Participants will be randomized 1:1, stratified by age cohort, to either group A (control period prior to AIDANET use) or group B (control period after AIDANET use).
Recruiting1 award N/A17 criteria
More about Mark DeBoer, MD
Clinical Trial Related3 years of experience running clinical trials · Led 4 trials as a Principal Investigator · 2 Active Clinical TrialsTreatments Mark DeBoer, MD has experience with
- AI-based Advisor System
- Artificial Pancreas (AP)
- Multidisciplinary State-of-the-Art Approach
- AIDANET System
Breakdown of trials Mark DeBoer, MD has run
Type 1 Diabetes
Other Doctors you might be interested in
Frequently asked questions
Do I need insurance to participate in a trial?
Almost all clinical trials will cover the cost of the ‘trial drug’ — so no insurance is required for this. For trials where this trial drug is given alongside an already-approved medication, there may be a cost (which your insurance would normally cover).
What does Mark DeBoer, MD specialize in?
Mark DeBoer, MD focuses on Type 1 Diabetes and Asthma. In particular, much of their work with Type 1 Diabetes has involved treating patients, or patients who are undergoing treatment.
Is Mark DeBoer, MD currently recruiting for clinical trials?
Yes, Mark DeBoer, MD is currently recruiting for 2 clinical trials in Charlottesville Virginia. If you're interested in participating, you should apply.
Are there any treatments that Mark DeBoer, MD has studied deeply?
Yes, Mark DeBoer, MD has studied treatments such as AI-based Advisor system, Artificial Pancreas (AP), Multidisciplinary State-of-the-Art Approach.
What is the best way to schedule an appointment with Mark DeBoer, MD?
Apply for one of the trials that Mark DeBoer, MD is conducting.
What is the office address of Mark DeBoer, MD?
The office of Mark DeBoer, MD is located at: University of Virginia, Charlottesville, Virginia 22903 United States. This is the address for their practice at the University of Virginia.
Is there any support for travel costs?
The coverage of travel expenses can vary greatly between different clinical trials. Please see more financial detail in the trials you’re interested to apply.